Literature DB >> 8349755

Reproducibility of lysis-centrifugation cultures for quantification of Mycobacterium avium complex bacteremia.

D Havlir1, C A Kemper, S C Deresinski.   

Abstract

While quantitative mycobacterial blood cultures have been accepted as the standard for evaluating response to various Mycobacterium avium complex (MAC) treatment regimens, variability in this methodology has not been evaluated in a rigorous fashion. We thus studied the reproducibility of quantitative MAC cultures by a lysis-centrifugation culture system within and among five institutions. To measure the intralaboratory variation in mycobacterial colony counts, colony counts from duplicate blood specimens collected from 52 AIDS patients with MAC bacteremia were determined. Colony counts ranged from 0 to 50,000 CFU/ml. Nonparametric analyses revealed there was no significant difference in colony counts between the 52 duplicate specimens. The agreement between the intralaboratory paired specimens, as measured by the intraclass correlation coefficient, was 0.997. To measure the interlaboratory variation, multiple 10-ml aliquots from 12 patients were distributed to five institutions and processed within 24 to 32 h by lysis-centrifugation. For the 12 specimens distributed to the five laboratories, two-way analysis of variance for repeated measures revealed no significant difference in an individual patient's colony counts between laboratories (P > 0.2). We conclude that quantitation of mycobacterial colony counts by the lysis-centrifugation system is reproducible within and between institutions. Clinical trials evaluating response to therapeutic interventions for MAC can use multiple laboratories for quantitation of mycobacteremia. Furthermore, a 24- to 32-h delay in processing appeared to have no impact on reproducibility.

Entities:  

Mesh:

Year:  1993        PMID: 8349755      PMCID: PMC265634          DOI: 10.1128/jcm.31.7.1794-1798.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

Authors:  J Chiu; J Nussbaum; S Bozzette; J G Tilles; L S Young; J Leedom; P N Heseltine; J A McCutchan
Journal:  Ann Intern Med       Date:  1990-09-01       Impact factor: 25.391

3.  Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers.

Authors:  J B Greene; G S Sidhu; S Lewin; J F Levine; H Masur; M S Simberkoff; P Nicholas; R C Good; S B Zolla-Pazner; A A Pollock; M L Tapper; R S Holzman
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

4.  Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.

Authors:  C A Kemper; T C Meng; J Nussbaum; J Chiu; D F Feigal; A E Bartok; J M Leedom; J G Tilles; S C Deresinski; J A McCutchan
Journal:  Ann Intern Med       Date:  1992-03-15       Impact factor: 25.391

5.  Effect of delays in processing on the survival of Mycobacterium avium-M. intracellulare in the isolator blood culture system.

Authors:  C F von Reyn; S Hennigan; S Niemczyk; N J Jacobs
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

6.  Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome.

Authors:  A M Macher; J A Kovacs; V Gill; G D Roberts; J Ames; C H Park; S Straus; H C Lane; J E Parrillo; A S Fauci
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

7.  Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome.

Authors:  B Wong; F F Edwards; T E Kiehn; E Whimbey; H Donnelly; E M Bernard; J W Gold; D Armstrong
Journal:  Am J Med       Date:  1985-01       Impact factor: 4.965

  7 in total
  6 in total

1.  PCR-hybridization assay for Mycobacterium avium complex: optimization of detection in peripheral blood from humans.

Authors:  G Ferrario; A Gori; A Rossi; L Catozzi; C Molteni; G Marchetti; A Bandera; M C Rossi; A D Esposti; F Franzetti
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Preparation of mycobacterial DNA from blood culture fluids by simple alkali wash and heat lysis method for PCR detection.

Authors:  J K Kulski; T Pryce
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

3.  The changing pattern of nontuberculous mycobacterial disease.

Authors:  Joseph O Falkinham
Journal:  Can J Infect Dis       Date:  2003-09

Review 4.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

Review 5.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Use of PCR in detection of Mycobacterium avium complex (MAC) bacteremia: sensitivity of the assay and effect of treatment for MAC infection on concentrations of human immunodeficiency virus in plasma.

Authors:  R R MacGregor; K Dreyer; S Herman; P K Hocknell; L Nghiem; V J Tevere; A L Williams
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.